Leadership
Ian Kavanagh
–
Chief Executive Officer
20 years’ experience in Biotech industry, with proven track record of MDx instrument and assay product launches
APIS, COO, 2018 - 2023
QIAGEN, Molecular Diagnostics, UK
Roche Diagnostics, Switzerland
Thermo Fisher Scientific, London & Helsinki
PhD in Molecular Biology
Helen Fielder – Head of Services & Operations
Over 15 years’ experience in Biotech industry in product development
QIAGEN Germany, Switzerland and UK
MDx assay development, system integration and technical writing
DPhil in Biochemistry
Nora Karnowski –
Head of Technology
Co-founder & Managing Director of Clickmer Systems GmbH
PhD in Molecular Biomedicine
MBA in Pharma Business Administration
Aleksandar Mihajlović
–
Head of Bioinformatics and Software
Experienced bioinformatics leader
Beogenomics – Managing Director
Seven Bridges – Internal Education Coordinator (Belgrade)
Seven Bridges Genomics – Bioinformatics Engineer
MS in Bioinformatics
Joachim Schorr – Executive Chair of the Board
30 years’ experience of executive management and product development in the Life Sciences and Diagnostics industry
APIS – CEO, 2018 - 2023
QIAGEN – Managing Director
Caris Life Sciences – CSO
JS Consulting
PhD in Virology and Immunology
Rowena Burns – Non-Executive Director
Works extensively with Universities, major hospitals, and industry partners, within the UK city of Manchester
Chairman of Manchester Science Partnerships
Chair of Health Innovation Manchester
Group Director Manchester Airport Group
Chief Operating Officer Bruntwood Estates
Mark Rahn
–
Non-Executive Director
Undertaken multiple roles as CEO, investor/non-executive director in a wide-range of companies in the technology sector
Led multiple investment rounds in numerous businesses.
Defined business strategies that lead to growth, investment, and long-term value creation
Guest speaker at Manchester Business School